ライフサイエンスコーパス: defer

1 eptember 2006 in which revascularization was deferred.

2 owever, the diagnosis is sometimes extremely deferred.

3 iverticulitis episode, is being increasingly deferred.

4 s after 8 weeks, nephrectomy procedures were deferred.

5 n and antibiotics, and hardware excision was deferred.

6 til a dry macula was achieved, and treatment deferred.

7 cipients with a previous malignancy is often deferred 2 to 5 years after cancer treatment due to fear

8 herapy upfront vs postoperative radiotherapy deferred (5-year OS: 82.0% vs 63.4%; P < .001).

9 delayed outcomes predict that people should defer a punishment, whilst advancing a reward.

10 patients would need to undergo spirometry to defer a single exacerbation.

11 us value only when participants rejected (or deferred accepting) a prospect.

12 The Deferred Action for Childhood Arrivals (DACA) program gr

13 he physical and mental health effects of the Deferred Action for Childhood Arrivals (DACA) programme,

14 cision variable signal during decisions with deferred actions with and without foreknowledge of stimu

15 ed, and their dynamics during decisions with deferred actions with or without foreknowledge of stimul

16 lar adrenal rest tumour was made; biopsy was deferred and hormonal treatment was modified.

17 , task transfer occurred under conditions of deferred and rearranged feedback-both species completed

18 , 123 (15.1%) had postoperative radiotherapy deferred, and 693 (84.9%) had postoperative radiotherapy

19 f an expedited approach compared with a much deferred angiography.

20 f multiple S. salivarius strains by use of a deferred-antagonism test showed that S. salivarius strai

21 8 infection-unrelated) and 39 cancers in the deferred arm (23 infection-related and 16 infection-unre

22 oL by day 14, compared with 0% (0/27) in the deferred arm (P = .002).

23 Providers who defer ART are also cautious about PrEP.

24 (+) cell count >500/microL, clinicians would defer ART if patients did not feel ready to initiate ART

25 uently and has been suggested as a reason to defer ART.

26 d illness was lower with early ART than with deferred ART (adjusted hazard ratio, 0.56; 95% CI, 0.41

27 ly assigned to one of four treatment groups: deferred ART (ART initiation according to WHO criteria),

28 of severe bacterial infection compared with deferred ART (hazard ratio [HR] 0.39, 95% CI 0.26-0.57,

29 y elevated with earlier ART as compared with deferred ART (hazard ratio, 3.87; 95% CI, 1.41 to 10.58;

30 ed to lower rates of severe illness than did deferred ART and no IPT, both overall and among patients

31 Patients were assigned to immediate versus deferred ART eligibility, as determined by a CD4 count <

32 ces in FEV1 slopes between the immediate and deferred ART groups either in smokers (difference of -3.

33 s resulted in higher mortality compared with deferred ART initiation (1-2 weeks vs 5 weeks postmening

34 nitiation was significantly higher than with deferred ART initiation (45% [40 of 88 patients] vs. 30%

35 initiation (1 to 2 weeks after diagnosis) or deferred ART initiation (5 weeks after diagnosis).

36 o investigate the effect of immediate versus deferred ART on decline in lung function in HIV-positive

37 to quantify the effects of immediate versus deferred ART on the risk of severe bacterial infection i

38 (ART initiation according to WHO criteria), deferred ART plus IPT, early ART (immediate ART initiati

39 d to immediate ART for 96 weeks (ART-96W) or deferred ART until clinical or immunological progression

40 Clinicians who deferred ART were less likely to endorse and engage in a

41 means to individualize patients to early or deferred ART.

42 tervention (early ART; n = 490) and control (deferred ART; n = 467) groups.

43 Deferring ART for 5 weeks after the diagnosis of cryptoc

44 We examined the effect of immediate (versus deferred) ART on retention in care using a regression di

45 ional models to compare outcomes between the deferred-ART and early-ART strategies and between the IP

46 cantly between the earlier-ART group and the deferred-ART group (20% and 13%, respectively; P=0.32).

47 dical imaging examinations may be delayed or deferred as a consequence, resulting in a much greater r

48 ts, in which revascularization can be safely deferred, as opposed to those at high risk when ischemic

49 Definitive removal of the mass was deferred at the time of Caesarian section to minimize po

50 isons were made between trial arms (early vs deferred) at 1, 8, 14, and 21 days following meningitis

51 mester, but complete removal of the mass was deferred because of fears the pregnancy would be lost.

52 Patients whose treatment was deferred by 2 years (randomized initially to sham) did n

53 In the DANAMI-3-DEFER cardiac magnetic resonance substudy, routine defer

54 edical bills (OR, 8.9; 95% CI, 4.4 to 18.0); deferring care for a medical problem (OR, 3.0; 95% CI, 1

55 on-unrelated); hazard ratios of immediate vs deferred cART initiation were 0.26 (95% confidence inter

56 Similar to prior studies, none of the deferred cases had HSV encephalitis (n = 3120).

57 stroke mortality, stroke risks (immediate vs deferred CEA) were 4.1% versus 10.0% at 5 years (gain 5.

58 nt in overall survival with immediate versus deferred chemotherapy after radical cystectomy and bilat

59 [high-dose MVAC], or MVAC) or six cycles of deferred chemotherapy at relapse, with stratification fo

60 of 68 patients who received treatment in the deferred chemotherapy group, neutropenia occurred in 49

61 ascertainment explain some of these trends, deferred childbearing, increasing population rates of co

62 Humans seek more information and defer choosing when they realize they have insufficient

63 0994 trial aimed to compare immediate versus deferred cisplatin-based combination chemotherapy after

64 itis, providing evidence for the practice of deferring colectomy for patients without persistent symp

65 OLD signals reflected two decision biases-to defer commitments to later, and to weight potential loss

66 Deferred consent is acceptable to the majority of respon

67 o which ICU patients or surrogates support a deferred consent process for a minimal risk study withou

68 Most patients and surrogates accept a deferred consent process for minimal risk research in th

69 nstitutional Review Boards should consider a deferred consent process if the subject lacks capacity a

70 e most common reason given for endorsing the deferred consent process was the stress of the early ICU

71 -four of 60 individuals (73%) approached for deferred consent responded positively to the question "D

72 erwise, a waiver of consent was granted, and deferred consent was sought 3 days later.

73 Main outcome measures were acceptability of deferred consent; timing of requesting consent; and the

74 ator avoidance and growth in the short term, deferring costs to a period when they are less vulnerabl

75 Under base case conditions, the deferred DAA treatment strategy was found to be the "dom

76 compared pretransplant DAA treatment versus deferred DAA treatment using a cost-effectiveness decisi

77 Nurses who attributed the responsibility deferred decisions about initiating ambulation to either

78 Median ability to defer defecation improved from seconds preoperatively to

79 The mean St Mark's score, ability to defer defecation, and the number of incontinent episodes

80 , this KD seems nutritionally safe and could defer dialysis initiation in some patients with CKD.

81 In certain systems, cells defer differentiation for extended time periods after th

82 d day 7 postreperfusion, coinciding with the deferred edema wave, were similar to values measured by

83 ice probing approach and the observation and deferred facility probing approach are successful and re

84 Eight participants in the observation and deferred facility probing group underwent facility probi

85 In the observation and deferred facility probing group, resolution without surg

86 one eye for 3 (10%); in the observation and deferred facility probing group, treatment success occur

87 ants who received ranibizumab plus prompt or deferred focal/grid laser treatment vs 3.4% for the part

88 other severe acute brain injuries should be deferred for >/=24 hrs if there are concerns or inconsis

89 and HSCT (n = 23) or control treatment (HSCT deferred for 1 year [n = 22]).

90 other severe acute brain injuries should be deferred for 24 hours or longer if there are concerns or

91 or for prevention of sudden cardiac death is deferred for 90 days after coronary revascularization, b

92 rn to activity recommendations are thus best deferred for most hospitalized MTBI children until forma

93 ream to all patients prior to angiography or deferred for selective use in the catheterization labora

94 etic diversity among 390 volunteers who were deferred from enrollment in RV144 due to preexisting HIV

95 t-effective when less than 1 in 200 patients deferred from testing truly had an HSV CNS infection.

96 Because persons with eczema are deferred from vaccination, only a single, accidentally t

97 outcome was assessment of noninferiority of deferred Gp IIb/IIIa inhibitor use compared with upstrea

98 roup (1.2/100 person-years) versus 20 in the deferred group (9.0/100 person-years) despite 174 prescr

99 riptions of post-exposure prophylaxis in the deferred group (relative reduction 86%, 90% CI 64-96, p=

100 eline to 5 years, 56% of participants in the deferred group did not receive laser.

101 ants (275 in the immediate group, 269 in the deferred group) between Nov 29, 2012, and April 30, 2014

102 versus 222 (90%) of 245 patient-years in the deferred group.

103 ents in the upstream group compared with the deferred group.

104 Xpert (immediate Xpert) or microscopy (Xpert deferred) group (1:1), stratified by province.

105 (with resumption if worsening) and prompt or deferred (>/=24 weeks) focal/grid laser treatment.

106 orsening) and random assignment to prompt or deferred (>/=24 weeks) focal/grid laser treatment.

107 g of intravitreal ranibizumab with prompt or deferred (>/=24 weeks) laser, or 4 mg of intravitreal tr

108 was 6.9%; patients in whom all lesions were deferred had a lower MACE rate (5.3%) than those with at

109 Deferring HCV treatment until after liver transplant and

110 The deferred healing-related edematous wave was blunted or a

111 ors have proposed and validated criteria for deferring HSV PCR testing of CSF in immunocompetent host

112 vere disease, valve procedures can safely be deferred if patients experience no symptoms and have nor

113 likely to display sequential memory during a deferred imitation memory task (P-trend = 0.048), and to

114 Tests included memory (deferred imitation, relational binding, habituation) and

115 Deferring immediate ADT in men with positive lymph nodes

116 Initial therapy is deferred in a small subset of patients.

117 suggest that renal transplantation should be deferred in liver recipients at high risk for RAF.

118 hile safely allowing revascularization to be deferred in low-risk lesions, resulting in a decrease in

119 us coronary intervention (PCI) is frequently deferred in patients with chronic kidney disease (CKD) t

120 Cerebrospinal fluid (CSF) analysis is often deferred in patients with cryptococcal disease, particul

121 Ablation was deferred in the remaining 7 for pathway proximity to the

122 emic heart disease (IHD) is often delayed or deferred in women.

123 viously reported, we analyzed the outcome of deferred initial therapy.

124 In selected asymptomatic patients with MCL, deferred initial treatment ("watch and wait") is an acce

125 s is mechanistically twofold, resulting from deferred initiation of axonal WD and reduced PI3K/Draper

126 -years), as compared with 96 patients in the deferred-initiation group (4.1%; 1.38 events per 100 per

127 cell count 194 cells per muL higher than the deferred-initiation group (p<0.0001).

128 nswered and recommended that patients in the deferred-initiation group be offered antiretroviral ther

129 infections (immediate-initiation group n=34, deferred-initiation group n=86; median 2.8 years of foll

130 dictated the use of antiretroviral therapy (deferred-initiation group).

131 value only when acceptance or rejection was deferred into the future, suggesting a role in integrati

132 why cholera vaccination campaigns have been deferred is plausible, we believe that the biggest barri

133 mediately (immediate-initiation group) or to defer it until the CD4+ count decreased to 350 cells per

134 Some may try to avoid or defer it.

135 er scores from baseline in the ranibizumab + deferred laser (N = 111), ranibizumab + prompt laser (N

136 pt laser (P = .25), 7% with ranibizumab with deferred laser (P = .001), and 37% with triamcinolone wi

137 b plus prompt laser (R+pL), ranibizumab plus deferred laser (R+dL), and triamcinolone plus laser (T+L

138 terval) in mean change between ranibizumab + deferred laser and laser/very deferred ranibizumab and t

139 aser group compared with +9.8 letters in the deferred laser group (mean difference, -2.6 letters; 95%

140 At the 5-year visit in the prompt versus deferred laser groups, there was vision loss of >/=10 le

141 reated with ranibizumab and either prompt or deferred laser maintain vision gains obtained by the fir

142 f phakic patients with DME, ranibizumab with deferred laser provided an additional 6 letters correct

143 ed data from the ranibizumab plus prompt and deferred laser treatment arms of the Diabetic Retinopath

144 edema (DME) with ranibizumab plus prompt or deferred laser versus triamcinolone plus prompt laser.

145 mcinolone with laser versus ranibizumab with deferred laser was $14 690 per letter gained.

146 zumab (0.5 mg) with either (1) prompt or (2) deferred laser; (3) sham injection + prompt laser; or (4

147 f intravitreal ranibizumab is no better than deferring laser treatment for >/=24 weeks in eyes with D

148 and possibly worse, for vision outcomes than deferring laser treatment for 24 weeks or more in eyes w

149 rs of target lesion revascularization in the deferred lesions were proximal location of the lesion, B

150 vaccination highlights the potential need to defer live virus vaccines for at least 6 months in expos

151 han half of eyes in which laser treatment is deferred may avoid laser for at least 5 years, such eyes

152 n extra synchronous division and temporarily deferred mid-blastula transition (MBT) events.

153 omly assigned to either immediate (n=518) or deferred (n=508) ART.

154 infection, pigs typically develop a weak and deferred NAb response.

155 lso be related to worse outcomes if patients defer necessary care.

156 (528 lesions) in whom revascularization was deferred on the basis of a nonischemic FFR (>0.75).

157 ents with percutaneous coronary intervention deferred on the basis of nonischemic FFR.

158 specific loss of HB-EGF in the uterus still defers on-time implantation without altering preimplanta

159 arin-binding EGF-like growth factor (HB-EGF) defers on-time implantation, leading to compromised preg

160 icitis that may eventually allow surgeons to defer operation for those cases of nonperforating append

161 to consider a tissue-preserving approach and defer or avoid radical therapy.

162 option for women at high risk of OC/FTC who defer or decline RRSO, given its high sensitivity and si

163 andomly assigned to receive ranibizumab plus deferred or prompt focal/grid laser treatment.

164 ys of surgery or "postoperative radiotherapy deferred" otherwise.

165 f 8-year-olds had postoperative radiotherapy deferred (P < .001).

166 mittee recommended on Oct 13, 2014, that all deferred participants be offered PrEP.

167 Deferring percutaneous coronary intervention in nonische

168 Deferring percutaneous coronary intervention on the basi

169 te a change in goal-directed behaviours from deferred predicted rewards to immediate actual rewards,

170 Surgery was deferred primarily due to medical inoperability or unres

171 or randomisation to immediate quinacrine or deferred quinacrine in an open-label, patient-preference

172 sk of severe neurotoxicity by withholding or deferring radiation therapy also appears feasible.

173 ed to compare prophylactic radiotherapy with deferred radiotherapy (given only when a PTM developed)

174 to receive immediate radiotherapy (n=102) or deferred radiotherapy (n=101).

175 thin 42 days of the pleural intervention) or deferred radiotherapy (same dose given within 35 days of

176 grade 2 in two [40%] of five patients in the deferred radiotherapy group who received radiotherapy fo

177 diate radiotherapy group vs two [40%] in the deferred radiotherapy group) within 3 months of receivin

178 s seen in PTM incidence in the immediate and deferred radiotherapy groups (nine [9%] vs 16 [16%]; odd

179 ab (N = 198), and triamcinolone + laser/very deferred ranibizumab (N = 125) groups were 10 +/- 13, 8

180 bizumab + prompt laser (N = 124), laser/very deferred ranibizumab (N = 198), and triamcinolone + lase

181 ranibizumab + deferred laser and laser/very deferred ranibizumab and triamcinolone + laser/very defe

182 er or triamcinolone + laser followed by very deferred ranibizumab for persistent thickening and visio

183 d ranibizumab and triamcinolone + laser/very deferred ranibizumab was 4.4 (1.2-7.6, P = .001) and 2.8

184 hospitalizations over 6 months could also be deferred, reducing costs associated with screening.

185 can engage in capital breeding and need not defer reproduction to forage; low reproductive overheads

186 rization versus initial medical therapy with deferred revascularization and insulin sensitization ver

187 mplications regarding the ability to realize deferred rewards, is associated with loss and risk avers

188 extent to which people can expect to realise deferred rewards, leading to more present-oriented behav

189 dent controls caused lethality in cells with deferred S phase, accompanied by Rad52 foci and chromoso

190 receive either routine upstream (n=4605) or deferred selective (n=4602) Gp IIb/IIIa inhibitor admini

191 an cancers perturbs this kinetic balance and defers splicing to occur entirely post-release.

192 ns unclear how this circuit enables cells to defer sporulation for multiple cell cycles.

193 This study sought to evaluate the effect of deferred stent implantation on infarct size, myocardial

194 Deferred stenting did not reduce final infarct size (9%

195 cardiac magnetic resonance substudy, routine deferred stenting did not reduce infarct size or MVO and

196 salvage index at 6 months was greater in the deferred stenting group (68 [IQR: 54% to 82%] vs. 56 [IQ

197 grades at the end of PCI were higher in the deferred stenting group (p = 0.018).

198 ecurrent STEMI occurred in 2 patients in the deferred stenting group before the second procedure.

199 Fewer patients in the deferred stenting group had no-/slow-reflow (14 [29%] vs

200 e [IQR]) time to the second procedure in the deferred stenting group was 9 h (IQR: 6 to 12 h).

201 years; 69% male) were randomized (52 to the deferred stenting group, 49 to the immediate stenting).

202 In high-risk STEMI patients, deferred stenting in primary PCI reduced no-reflow and i

203 se results do not support the use of routine deferred stenting in STEMI patients treated with primary

204 The aim of this study was to assess whether deferred stenting might reduce no-reflow and salvage myo

205 In patients with a stent length >/=24 mm, deferred stenting reduced the final infarct size (6% LV;

206 Similarly, deferred stenting was not associated with myocardial sal

207 Randomization was to deferred stenting with an intention-to-stent 4 to 16 h l

208 percutaneous coronary intervention (PCI) and deferred stenting.

209 rbidities, low weight) relieves cyanosis and defers surgical repair.

210 ned to undergo an immediate switch (IS) or a deferred switch (DS; at week 24) from an enfuvirtide-bas

211 minates such minimal-risk patients, for whom deferred testing may be considered.

212 rtance of health status as an end point, and deferred testing options.

213 Here we use a strategy to defer the thermal depolarization, even render depolariza

214 ing by lowering the freezing temperature and deferring the growth of ice, are present at high levels

215 ven reverse existing myocardial dysfunction, deferring the need for heart transplantation.

216 S undergoing an invasive treatment strategy, deferring the routine upstream use of Gp IIb/IIIa inhibi

217 ocardial salvage when stent implantation was deferred, the DANAMI-3-DEFER (Third DANish Study of Opti

218 Timers help cells defer their responses to stimuli, often for time interva

219 administration of GP IIb/IIIa inhibitors vs deferring their use for patients undergoing PCI.

220 tervention, and those with low levels should defer therapy for potential spontaneous clearance.

221 n chemotherapy in 20 of 24 patients), and 12 deferred therapy until after delivery.

222 rly-therapy group) with that of patients who deferred therapy until the CD4+ count fell below these t

223 s were randomly assigned 3:1 to immediate or deferred therapy.

224 00 cells per cubic millimeter and 6935 (76%) deferred therapy.

225 ficantly improved survival, as compared with deferred therapy.

226 0 cells per cubic millimeter, and 6278 (75%) deferred therapy.

227 nical characteristics, among patients in the deferred-therapy group there was an increase in the risk

228 the CD4+ count fell below these thresholds (deferred-therapy group).

229 he early-therapy group (relative risk in the deferred-therapy group, 1.69; 95% confidence interval [C

230 Among patients in the deferred-therapy group, there was an increase in the ris

231 tent implantation was deferred, the DANAMI-3-DEFER (Third DANish Study of Optimal Acute Treatment of

232 institutions differ in their willingness to defer to a single, central institutional review board (I

233 e concentrated solutions, these interactions defer to an organized supramolecular assembly, leading t

234 It is sometimes ethically permissible to defer to family values regarding nondisclosure, but such

235 wn prior convictions, but they may sometimes defer to informants for inherently social reasons.

236 ate that in areas of ambiguity it is best to defer to parents' views, whereas others indicate concern

237 t the euthanasia review committees generally defer to the judgments of the physicians performing the

238 nsion of Hubbell's metacommunity dynamics is deferred to an appendix.

239 ion code in eye-centered visual cortex or is deferred to downstream areas.

240 erges already in primary sensory areas or is deferred to higher-order association areas.

241 arance of those innovations, but are instead deferred to periods of high extinction rate.

242 the other 84 patients, 28 (33%) had therapy deferred to postpartum; these patients were diagnosed at

243 eam GP IIb/IIIa administration and 4602 were deferred to selective GP IIb/IIIa inhibitor administrati

244 ing a 30% decline in SUV for "response," and deferring to RECIST 1.1 in cases that do not have (18)F-

245 ation for surgical airway, clinicians should defer tracheostomy placement for at least 2 wks followin

246 ESPECT mental health training programme or a deferred training control group.

247 ted to the control group were entered in the deferred training group.

248 te treatment at the time of assessment or to defer treatment should take into consideration other fac

249 with immediate treatment when compared with deferred treatment (adjusted HR 0.78, 95% CI 0.56-1.08;

250 t exudative features at study entry received deferred treatment (after 1 month observation), when exu

251 ment (cardiac arrest) and three who received deferred treatment (aortic aneurysm, pneumonia, and unkn

252 nged progression-free survival compared with deferred treatment (HR 0.54, 95% CI 0.4-0.73, p<0.0001),

253 One serious adverse event during deferred treatment (interstitial nephritis) and one duri

254 phritis) and one during the placebo phase of deferred treatment (raised lipase concentration) were de

255 (immediate treatment [IT]) or no treatment (deferred treatment [DT]).

256 lt of PCa were compared between patients who deferred treatment and those who underwent immediate tre

257 for time to eventual treatment among men who deferred treatment for more than 1 year after diagnosis.

258 with grazoprevir and elbasvir (n=111) or the deferred treatment group (n=113), and 11 were assigned t

259 rences in aminotransferase elevations in the deferred treatment group compared with the immediate tre

260 rmacokinetic population and five (4%) in the deferred treatment group discontinued because of an adve

261 iate treatment group, and no patients in the deferred treatment group had total bilirubin elevations.

262 ate treatment group and placebo phase of the deferred treatment group have been reported previously.

263 16), unmasking occurred and patients in the deferred treatment group received grazoprevir and elbasv

264 itor; immediate treatment group) or placebo (deferred treatment group) once daily for 12 weeks.

265 e per day for 12 weeks beginning at week 16 (deferred treatment group).

266 efficacy data for the treatment phase of the deferred treatment group, as well as HRQOL assessed usin

267 Of the three deaths in the deferred treatment group, one occurred during placebo tr

268 treatment and those receiving placebo in the deferred treatment group.

269 treatment group and 31.8% (24.2-39.6) in the deferred treatment group.

270 etween the immediate treatment group and the deferred treatment group.

271 ad died compared with 82 (57%) of 143 in the deferred treatment group.

272 ere compared between immediate treatment and deferred treatment groups using the stratified Miettinen

273 igned (141 to immediate treatment and 143 to deferred treatment), and followed up until the data cuto

274 73%) patients died: one randomly assigned to deferred treatment, 26 of 38 who chose immediate quinacr

275 ed to immediate treatment and 99 assigned to deferred treatment.

276 imately a third of patients going on to have deferred treatment.

277 PCa from 1986 to 2007, 342 (10.3%) initially deferred treatment.

278 with 97 (98.0%; 92.9-99.7) of 99 assigned to deferred treatment.

279 immediate treatment and the placebo phase of deferred treatment.

280 an 3 cm are very unlikely to metastasize and deferring treatment has not been associated with increas

281 These findings support deferring treatment with prasugrel until a decision is m

282 ed to the immediate-treatment group (ITG) or deferred-treatment group (DTG; placebo followed by activ

283 tion results in whom immediate treatment was deferred ultimately returned with appendicitis.

284 ical periodontal treatment, whereas this was deferred until after delivery for controls.

285 lt in better neurologic function than repair deferred until after delivery.

286 hed; if possible, these procedures should be deferred until after parturition.

287 ermediate, with large-scale domain rotations deferred until after promoter release.

288 e splicing, it is important that splicing be deferred until all of the exons and introns involved in

289 Services guidelines) either immediately, or deferred until CD4 T-cell counts decreased to 350 per mu

290 refore, cross-sectional chest imaging may be deferred until development of abdominal disease, with mi

291 ia occurred in 16.3% of patients assigned to deferred use compared with 15.2% of patients assigned to

292 ays occurred in 7.9% of patients assigned to deferred use compared with 7.1% of patients assigned to

293 Deferred use compared with upstream use resulted in redu

294 ents, or median infant birth weight based on deferred versus antenatal therapy.

295 ients with STEMI were randomized to PCI with deferred versus immediate stent implantation.

296 within the micturition control circuitry, to defer voiding and maintain urinary continence, even when

297 Conversely, the deferred wave of edema appears progressively days after

298 The role of tissue healing in the deferred wave of edema was evaluated by comparing pigs u

299 fusion and dissipates at 24 h, followed by a deferred wave that initiates days after infarction, peak

300 stenosis was grafted with an FFR </=0.80 or deferred with an FFR >0.80 (FFR-guided group).